CRT Reiterates On Edwards Lifesciences, Sees 'Many Future Growth Opportunities'
February 04, 2015 at 14:57 PM EST
CRT reiterated its Buy rating and $150 price target on Edwards Lifesciences Corp (NYSE: EW) Wednesday following the company’s ...